BTV-Business Television visits up-and-coming innovative investment opportunities.
(jump to 23:30 min)

Resverlogix (OTC: RVXCF)

BTV learns about this biotech pioneer in epigenetics – or gene regulation, and their flagship drug which recently became the subject of a trial to treat the effects of COVID-19.